Actively Recruiting
Study of Liver Fat and Fibrosis in Adults with Active Cushings Syndrome using MRI
Led by University Hospital, Angers · Updated on 2026-07-10
100
Participants Needed
7
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research focuses on Cushings Syndrome, a rare condition caused by prolonged exposure to high cortisol levels, often leading to metabolic issues like abdominal obesity and insulin resistance. The study also addresses Non-Alcoholic Fatty Liver Disease NAFLD, a condition characterized by liver fat accumulation without secondary causes, which can range from simple steatosis to serious liver inflammation and fibrosis. Researchers aim to better understand the presence and resolution of liver steatosis in patients with Cushings Syndrome, as current data on this topic in humans is limited. Participants will undergo hepatic MRI and Fibroscan assessments to evaluate liver fat and fibrosis. The study is a single-group diagnostic trial where hepatic MRI will quantify liver steatosis at diagnosis and one year after remission. The primary focus is to measure how often hepatic steatosis resolves over two years. Additional non-invasive biomarkers will also be used to assess liver fibrosis and steatosis prevalence during this period. During the study, participants will have imaging tests including hepatic MRI and Fibroscan to monitor liver condition. Researchers will collect data on the frequency of steatosis resolution and prevalence, as well as several liver fibrosis scores over two years. This will help track changes in liver health in relation to Cushings Syndrome and its treatment. The study provides ongoing evaluation to understand liver complications and their progression in affected individuals.
CONDITIONS
Brief Title
NAC- NAFLD And Cushing
Research Team
C
Claire BRIET
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here